SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/17/22 Clorox Co./DE 8-K:5,9 11/16/22 10:267K DG3/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 49K 5: R1 Cover HTML 45K 8: XML IDEA XML File -- Filing Summary XML 11K 6: XML XBRL Instance -- clx4131591-8k_htm XML 14K 7: EXCEL IDEA Workbook of Financial Reports XLSX 8K 4: EX-101.LAB XBRL Labels -- clx-20221116_lab XML 96K 3: EX-101.PRE XBRL Presentations -- clx-20221116_pre XML 63K 2: EX-101.SCH XBRL Schema -- clx-20221116 XSD 12K 9: JSON XBRL Instance as JSON Data -- MetaLinks 25± 32K 10: ZIP XBRL Zipped Folder -- 0001206774-22-002671-xbrl Zip 45K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i November 16, 2022
i THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
i 1-07151 |
||||
(State or other jurisdiction of |
(Commission File Number) |
(I.R.S. Employer |
(Address of principal executive offices) |
(Zip code) |
( i 510) i 271-7000 |
(Registrant's telephone number, including area code) |
Not applicable |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading | Name of each exchange on which registered |
Symbol(s) | ||
i Common Stock - $1.00 par value | i CLX | i New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
On November 16, 2022, The Clorox Company (the “Company”) held its virtual annual meeting of shareholders. The matters voted on and the results of the vote were as follows:
1. | The Company’s shareholders elected the following directors to each serve until the next Annual Meeting of Shareholders or until a successor is duly elected and qualified. |
Number of Votes | ||||||||
For | Against | Abstain | Broker Non-Votes | |||||
Amy L. Banse | 85,257,601 | 1,090,707 | 260,962 | 18,222,827 | ||||
Julia Denman | 85,663,547 | 679,455 | 266,267 | 18,222,827 | ||||
Spencer C. Fleischer | 84,833,382 | 1,491,959 | 283,930 | 18,222,827 | ||||
Esther Lee | 85,460,628 | 888,455 | 260,187 | 18,222,827 | ||||
A.D. David Mackay | 85,544,613 | 790,520 | 274,137 | 18,222,827 | ||||
Paul Parker | 85,692,013 | 641,810 | 275,448 | 18,222,827 | ||||
Stephanie Plaines | 85,600,327 | 743,060 | 265,883 | 18,222,827 | ||||
Linda Rendle | 85,542,167 | 802,236 | 264,867 | 18,222,827 | ||||
Matthew J. Shattock | 84,014,161 | 2,326,236 | 268,874 | 18,222,827 | ||||
Kathryn Tesija | 85,386,553 | 959,875 | 262,842 | 18,222,827 | ||||
Russell J. Weiner | 85,520,082 | 803,127 | 286,061 | 18,222,827 | ||||
Christopher J. Williams | 85,277,028 | 1,054,292 | 277,951 | 18,222,827 |
2. | The Company’s shareholders voted for (on an advisory basis) the approval of the compensation of the Company’s named executive officers. |
Number of Votes | ||||||
For | Against | Abstain | Broker Non-Votes | |||
80,870,158 | 5,199,569 | 539,543 | 18,222,827 |
3. | The Company’s shareholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2023. |
Number of Votes | ||||||
For | Against | Abstain | Broker Non-Votes | |||
102,642,634 | 1,870,724 | 318,740 | 0 |
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
See the Exhibit Index below.
Exhibit | Description | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE CLOROX COMPANY | ||||
Date: November 17, 2022 | By: | /s/ Angela Hilt | ||
Angela Hilt | ||||
Executive Vice President – Chief Legal Officer | ||||
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
6/30/23 | ||||
Filed on: | 11/17/22 | |||
For Period end: | 11/16/22 | DEF 14A | ||
List all Filings |